期刊文献+

冠状动脉血运重建对缺血性心力衰竭的治疗作用研究

Study on effect of coronary artery revascularization on the treatment of ischemic heart failure
下载PDF
导出
摘要 目的探究冠状动脉血运重建对缺血性心力衰竭的治疗作用。方法 40例缺血性心力衰竭患者作为研究对象,随机分为对照组与观察组,各20例。对照组给予常规治疗,观察组在对照组基础上增加血运重建治疗。对比两组治疗前后左室射血分数(LVEF)、左室舒张末期内径(LVEDD)、左室收缩末期内径(LVESD)改善情况以及6 min步行距离。结果治疗前,两组患者的LVEF、LVEDD、LVESD水平比较,差异均无统计学意义(P>0.05);治疗后,两组患者的LVEF、LVEDD、LVESD水平均较本组治疗前改善,且观察组改善程度优于对照组,差异均具有统计学意义(P<0.05)。治疗前,两组患者的6 min步行距离比较,差异无统计学意义(P>0.05);治疗后,两组患者的6 min步行距离均较本组治疗前增加,且观察组(392.10±21.44)m长于对照组的(365.84±20.58)m,差异均具有统计学意义(P<0.05)。结论给予缺血性心力衰竭患者冠状动脉血运重建进行治疗,能有效缓解患者的临床症状,改善预后。 Objective To investigate the effect of coronary artery revascularization on the treatment of ischemic heart failure. Methods A total of 40 patients with ischemic heart failure as study subjects were randomly divided into control group and observation group, with 20 cases in each group. The control group received conventional therapy, and the observation group received coronary artery revascularization. Comparison were made on improvement of left ventricular ejection fraction(LVEF), left ventricular end-diastolic diameter(LVEDD), left ventricular end-systolic diameter(LVESD) and 6-minute walking distance before and after treatment between the two groups. Results Before treatment, both groups had no statistically significant differences in LVEF, LVEDD, LVESD level(P>0.05). After treatment, both groups had improved LVEF, LVEDD, LVESD level than those before treatment, and the observation group had better improvement degree than the control group. The differences were statistically significant(P<0.05). Before treatment, both groups had no statistically significant difference in 6-minute walking distance(P>0.05). After treatment, both groups had increased 6-minute walking distance than those before treatment, and the observation group(392.10±21.44) m was longer than the control group(365.84±20.58) m. The differences were statistically significant(P<0.05). Conclusion Coronary artery revascularization for patients with ischemic heart failure can effectively relieve the clinical symptom of patients and improve their prognosis.
作者 朱虹岷 蔡新勇 曾晖 徐胜国 邵靓 王晶 洪浪 ZHU Hong-min;CAI Xin-yong;ZENG Hui(Department of Internal Medicine-Cardiovascular,Jiangxi People' s Hospital,Ganzhou 330006,China)
出处 《中国实用医药》 2018年第36期31-32,共2页 China Practical Medicine
基金 江西省卫生计生委科技计划(项目编号:20185013)
关键词 冠状动脉血运重建 缺血性心力衰竭 心功能 Coronary artery revascularization Ischemic heart failure Cardiac function
  • 相关文献

参考文献5

二级参考文献41

  • 1Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardialrevascularization : The task force on myocardial revascularization ofthe european society of cardiology ( ESC ) and the europeanassociation for cardio-thoracic surgery ( EACTS) [ J]. Eur Heart J,2010, 31 (20): 2501-2555.
  • 2Richards AM, Nicholls MG, Espiner EA, et al. B-type natriureticpeptides and ejection fraction for prognosis after myocardialinfarction [ J]. Circulation, 2003 , 107 (22) : 2786-2792.
  • 3Moller JE, Brendorp B, Ottesen M,et al. Congestive heart failurewith preserved left ventricular systolic function after acutemyocardial infarction: clinical and prognostic implications [ J]. EurJ Heart Fail,2003,5 (6) : 811-819.
  • 4Thygesen K,Alpert JS, White HD. Universal definition of myocardialinfarction [J]. J Am Coll Cardiol, 2007 , 50 (22) : 2173-2195.
  • 5Dickstein K, Cohen-Solai A,Filippatos G, et al. ESC Guidelines forthe diagnosis and treatment of acute and chronic heart failure 2008 : theTask Force for the Diagnosis and Treatment of Acute and Chronic HeartFailure 2008 of the European Society of Cardiology. Developed incollaboration with the Heart Failure Association of the ESC (HFA) andendorsed by the European Society of Intensive Care Medicine (ESICM )[J]. Eur Heart J, 2008 , 29 (19) : 2388-2442.
  • 6Hunt SA, Abraham WT, Chin MH, et al. 2009 focused updateincorporated into the ACC/AHA 2005 guidelines for the diagnosisand management of heart failure in adults : a report of the AmericanCollege of Cardiology Foundation/American Heart Association TaskForce on Practice Guidelines : developed in collaboration with theInternational Society for Heart and Lung Transplantation [ J ].Circulation, 2009, 119 (14) : e391479.
  • 7Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns ofin-stent restenosis : classification and implications for long-termoutcome [J]. Circulation, 1999, 100 (18): 1872-1878.
  • 8Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence andoutcome of heart failure with preserved ejection fraction [ J ]. NEngl J Med, 2006, 355 (3) : 251-259.
  • 9Tribouilloy C,Rusinaru D,Mahjoub H, et al. Prognostic impact ofdiabetes mellitus in patients with heart failure and preserved ejectionfraction : a prospective five-year study [ J ]. Heart,2008,94(11): 1450-1455.
  • 10Varela-Roman A, Grigorian L,Barge E, et al. Heart failure inpatients with preserved and deteriorated left ventricular ejectionfraction [J]. Heart, 2005, 91 (4) : 489 494.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部